Medi Caps shareholders approve all resolutions at 43rd AGM
- All three AGM resolutions passed with 98.77% overall approval
- Alok K Garg re-appointed as CMD for three years until August 2029
- Saloni Garg appointed as WTWD for three years until August 2029
- Public non-institutional shareholders voted 93% against director resolutions

*this image is generated using AI for illustrative purposes only.
Medi Caps Limited confirmed that all three resolutions proposed at its 43rd Annual General Meeting held on September 22, 2026, were approved by shareholders with the requisite majority. The company submitted the combined scrutinizer's report and voting results to BSE on September 23, 2026.
The meeting was conducted through video conference and other audio-visual means. A total of 57 members participated virtually out of 10,524 total members as of the cutoff date. The proceedings commenced at 12:30 pm with the registered office in Indore deemed as the venue. The company secretary briefed attendees on the VC/OAVM compliance protocols mandated by the Ministry of Corporate Affairs and SEBI.
Key agenda items transacted
The meeting addressed three primary resolutions regarding financial reporting and governance. The audited standalone and consolidated financial statements for the year ended March 31, 2026, were presented for adoption. Additionally, shareholders voted on the re-appointment of Chairman and Managing Director Alok K Garg and the confirmation of Whole-Time Woman Director Saloni Garg.
| Item | Resolution Details | Type | Result |
|---|---|---|---|
| 1 | Adoption of standalone and consolidated financial statements for FY26 | Ordinary | Passed |
| 2 | Re-appointment of Alok K Garg as CMD with remuneration | Special | Passed |
| 3 | Confirmation of Saloni Garg as Director and WTWD | Special | Passed |
Director appointment details
The new disclosures provide specific terms for the leadership roles confirmed at the meeting. Alok K Garg was re-appointed as Chairman and Managing Director for a period of three years, effective from September 1, 2026, to August 31, 2029. He holds a Bachelor of Business Administration (Honors) and an MBA in Marketing, along with more than 26 years of experience in the pharma industry and real estate sector.
Saloni Garg was appointed as Director and Whole-Time Woman Director effective August 7, 2026, for a term ending August 6, 2029. She holds a degree in Business Management from Mumbai and a Master’s in Brand Management from Italy, with experience as a freelance brand manager. The disclosure notes that Alok K Garg is the father-in-law of Saloni Garg. Both directors confirmed they are not debarred from holding office by SEBI or any other authority.
Voting results breakdown
According to the combined scrutinizer's report, the voting outcomes for all three resolutions were identical due to the high concentration of promoter holding. Promoters and promoter group members voted in favor across all items, while public non-institutional shareholders showed significant dissent against the director-related resolutions.
| Category | Votes Polled | Votes in Favour | Votes Against | % In Favour |
|---|---|---|---|---|
| Promoter and Promoter Group | 64,14,853 | 64,14,853 | 0 | 100% |
| Public Institutions | 0 | 0 | 0 | 0% |
| Public Non-Institutions | 86,128 | 6,128 | 80,000 | 7.12% |
| Total | 65,00,981 | 64,20,981 | 80,000 | 98.77% |
Governance and attendance details
The meeting was attended by the Board of Directors, including Independent Directors Ashok Omprakash Agrawal, Dharmendra Solanki, and Gajendra Singh. Statutory Auditor Venus Rawka, Internal Auditor Amit Parmar, and Secretarial Auditor L.N. Joshi were also present. No physical proxies were required due to the virtual format, except for corporate shareholders.
During the session, Chairman Alok K Garg provided insights into the company's real estate projects and the operational performance of its wholly owned subsidiary, Medgel Private Limited. He also summarized the company's fiscal year 2026 performance and future positioning. Although four members registered to speak, none joined the live session, resulting in no queries or suggestions being recorded during the open floor segment.
Voting process and conclusion
Remote e-voting facilities were active from September 19 to September 21, 2026. Members present during the AGM who had not previously voted were allowed to cast their votes electronically during the meeting. The scrutinizer, Darshika Wankhede, oversaw the voting process. The meeting concluded at 12:50 pm. The final voting results have been uploaded on the company's website and the CDSL e-voting portal.
Historical Stock Returns for Medi Caps
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.99% | -12.06% | -0.44% | -0.67% | -0.67% | -0.67% |
How will the significant dissent from public non-institutional shareholders regarding director re-appointments influence Medi Caps' future corporate governance reforms?
What specific strategic initiatives has Chairman Alok K Garg outlined for the real estate projects and subsidiary Medgel Private Limited to drive growth through 2029?
Given the high promoter concentration, how does Medi Caps plan to improve engagement with public shareholders to address the low participation and voting concerns?


































